Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06807086 · ClinicalTrials.gov registry record · NA
Efficacy of Synchronous, Virtual Cognitive Behavioral Therapy for Insomnia Across Phases of Cancer Survivorship
A NA study of Insomnia Chronic, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 198
- Enrollment target
- 1
- Study location
NCT06807086 is a NA study of Insomnia Chronic that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 198 participants, above the 106-participant average among 16 other Insomnia Chronic trials with a reported enrollment target (87% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06807086, a NA study of Insomnia Chronic, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 198 participants
- Enrollment target
- 1
- Study location
Study Summary
This project is a single center, prospective randomized controlled trial (N=198) primarily evaluating the efficacy of the Survivorship Sleep Program vs. Enhanced Usual Care on insomnia severity among cancer survivors. The investigators will also examine secondary outcomes associated with cancer-related insomnia including subjective and objective sleep measures (i.e., sleep diaries, actigraphy), emotional distress, fatigue, and use of sleep medications. Notably, most CBT-I trials with cancer survivors who have completed primary treatment with curative intent (i.e., curvivors) but not those in treatment or living with metastatic cancer (i.e., metavivors). To enhance generalizability, this RCT will stratify enrollment by survivorship phase (1:1:1). This project in strengthened by partnerships with community organizations (SurvivorJourneys and Ellie Fund) and use of both quantitative (i.e., surveys, actigraphy) and qualitative methods (i.e., interviews) to inform considerations for future implementation. Collectively, the proposed project will yield multiple deliverables to innovate cancer survivorship care, namely an efficacious, virtually delivered intervention addressing chronic insomnia, one of the most deleterious concerns among the growing population of cancer survivors in the US. Findings will inform a future effectiveness trial and the expansion of the synchronous delivery of CBT-I to survivors across different phases of cancer survivorship.
Conditions Studied
Interventions
- BEHAVIORAL Enhanced Usual Care
- BEHAVIORAL Cognitive Behavioral Therapy - Insomnia
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2025-01-01 |
| Est. Completion | 2028-12-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06807086
The ClinicalTrials.gov registry entry for NCT06807086 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 106-participant average among 16 other Insomnia Chronic trials with a reported enrollment target (87% higher). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Insomnia Chronic appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.
NCT06807086 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06807086 about?
NCT06807086 is a clinical study titled "Efficacy of Synchronous, Virtual Cognitive Behavioral Therapy for Insomnia Across Phases of Cancer Survivorship". This project is a single center, prospective randomized controlled trial (N=198) primarily evaluating the efficacy of the Survivorship Sleep Program vs. Enhanced Usual Care on insomnia severity among cancer survivors. The investigators will also examine secondary outcomes associated with cancer-rela...
What is the current status of trial NCT06807086?
This trial is currently recruiting. It is a NA study. The enrollment target is 198 participants. The study started on 2025-01-01. Estimated completion is 2028-12-28.
What conditions does trial NCT06807086 study?
This clinical trial studies the following conditions: Insomnia Chronic.
What interventions are being tested in trial NCT06807086?
The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Cognitive Behavioral Therapy - Insomnia (BEHAVIORAL).
Who is sponsoring clinical trial NCT06807086?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06807086 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sleep Treatment Education Program for Cancer Survivors: STEP-Together
RECRUITING · NA
-
SLEEP-COPE: Sleep Intervention for Oppositional Children
RECRUITING · NA
-
Targeting Insomnia in School Aged Children With Autism Spectrum Disorder
RECRUITING · NA
-
Digital Dyadic Family Based Intervention to Improve Sleep in Children with ODD and Their Parents: NiteCAPP SINCC (Pilot)
RECRUITING · NA
-
Web-based Cognitive Behavioral Treatment for Insomnia in Dementia Caregivers
RECRUITING · NA
-
Sleep Learning Education and Empowerment for Older Korean Immigrants
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.